Kidney Care Access Protection Act
Take action
Record your position on this measure.
Create an account to take a stance, submit a written position, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Overview
The Kidney Care Access Protection Act aims to improve access to innovative kidney care treatments under Medicare. It proposes extending a transitional drug add-on payment adjustment for new renal dialysis drugs and devices, establishing a permanent add-on adjustment, and expanding Medicare Advantage’s support for these therapies. The bill also addresses staffing barriers in kidney care through market basket labor adjustments and seeks to prevent kidney disease by expanding the annual wellness benefit to include kidney disease screening and increasing access to kidney disease education benefits.
Key provisions
- Extends the transitional drug add-on payment adjustment for new renal dialysis drugs and biological products.
- Creates a permanent add-on payment adjustment for new renal dialysis drugs and biological products.
- Ensures Medicare Advantage supports innovative kidney care therapies.
- Adjusts the ESRD market basket labor adjustments to improve accuracy and stability.
- Expands the Medicare annual wellness benefit to include kidney disease screening.
- Increases access to Medicare kidney disease education benefits.
- Modifies the calculation of the increase factor for the annual update of payment amounts for renal dialysis services.
- Requires the use of a modifier for claims related to new and innovative drugs or biological products.
Who is affected
- Medicare beneficiaries
- Renal dialysis providers
Bill text
Read the latest version inline or switch to a previous version.
Text extraction is in progress. View the official source.
Sponsors
Official sponsors from legislative records.
16 on record
Primary sponsor
Cosponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours